Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Name: Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic distal bile duct adenocarcinoma, metastatic gallbladder carcinoma, metastatic intrahepatic cholangiocarcinoma, recurrent distal bile duct adenocarcinoma, recurrent gallbladder carcinoma, recurrent intrahepatic cholangiocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160335
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.